18F-Flourodeoxyglucose positron emission tomography in polymyalgia rheumatica: Novel insight into complex pathogenesis but questionable use in predicting relapses

Rheumatology

Volumn 46, Issue 4, 2007, Pages 559-560

  Dejaco, C ^a   Duftner, C ^a   Wipfler, E ^a   Schirmer, Michael ^a  

^a GENERAL HOSPITAL KLAGENFURT   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

CLINICAL TRIAL; CYTOKINE PRODUCTION; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG WITHDRAWAL; EDITORIAL; ERYTHROCYTE SEDIMENTATION RATE; FRAGILITY FRACTURE; GIANT CELL ARTERITIS; HEADACHE; HISTOPATHOLOGY; HUMAN; LONG TERM CARE; LOW DRUG DOSE; MUSCLE STIFFNESS; NECK PAIN; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RELAPSE; RHEUMATIC POLYMYALGIA; TREATMENT DURATION; TREATMENT OUTCOME; PROGNOSIS; RECURRENT DISEASE; SCINTISCANNING;

FLUORODEOXYGLUCOSE F18; HUMANS; POLYMYALGIA RHEUMATICA; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RECURRENCE;

EID: 34047112908     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel377     Document Type: Editorial

References (17)

1. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica. Best Pract Res Clin Rheumatol 2004;18:705-22.
2. Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 2003;139:505-15.
3. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002;347:261-71.
4. Salvarani C, Macchioni PL, Tartoni PL et al. Polymyalgia rheumatica and giant cell arteritis: A 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol 1987;5:205-15.
5. Ayoub WT, Franklin CM, Torretti D. Polymyalgia rheumatica. Duration of therapy and long-term outcome. Am J Med 1985;79:309-15.
6. Gabriel SE, Sunku J, Salvarani C, O'Fallon WM, Hunder GG. Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum 1997;40:1873-8.
7. Pountain G, Hazleman B. Erythrocyte sedimentation rate (ESR) at presentation is a prognostic indicator for duration of treatment in polymyalgia rheumatica (PMR). Br J Rheumatol 1997;36:508-9.
8. Kyle V, Cawston TE, Hazleman BL. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis 1989;48:667-71.
9. Weyand CM, Fulbright JW, Evans JM, Hunder GG, Goronzy JJ. Corticosteroid requirements in polymyalgia rheumatica. Arch Intern Med 1999;159:577-84.
10. Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: A prospective study in 35 patients. Rheumatology 2007;46:668-673.
11. Schirmer M, Calamia KT, Wenger M, Klauser A, Salvarani C, Moncayo R. 18F-fluorodeoxyglucose-positron emission tomography: A new explorative perspective. Exp Gerontol 2003;38:463-70.
12. Moosig F, Czech N, Mehl C et al. Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: A quantitative PET study. Ann Rheum Dis 2004;63:870-3.
13. Salvarani C, Cantini F, Niccoli L et al. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: A prospective follow-up study. Arthritis Rheum 2005;53:33-8.
14. Blockmans D, de Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: A prospective study of 35 patients. Arthritis Rheum 2006;55:131-7.
15. Wenger M, Gasser R, Donnemiller E, Klauser A, Moncayo R, Schirmer M. Lymph node tuberculosis in a patient with polymyalgic symptoms: Value of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET). Z Rheumatol 2003;62:294-5.
16. Weyand CM, Tetzlaff N, Bjornsson J, Brack A, Younge B, Goronzy JJ. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 1997;40:19-26.
17. Frediani B, Falsetti P, Storri L et al. Evidence for synovitis in active polymyalgia rheumatica: Sonographic study in a large series of patients. J Rheumatol 2002;29:123-30.